Knowledge Distillery

Filter the news according their assigned tags.
| Cross-sectional case-control studies  

This nationwide study assessed the impact of the pandemic on stroke hospitalisation rates, patient characteristics, and 30‐day case fatality rates.

more...
| Cross-sectional case-control studies  

The effects of the COVID‐19 pandemic on telemedical care have not been described on a national level.

more...
| Cross-sectional case-control studies  

The authors conducted a longitudinal case-control 18F-FDG-PET study in patients diagnosed with COVID-19-related encephalopathy.

more...
| Randomised double-blinded placebo-controlled trial  

The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length SARS-CoV-2 spike protein in a…

more...
| Cross-sectional case-control studies  

Many pregnant persons in the United States are receiving messenger RNA (mRNA) COVID-19 vaccines, but data are limited on their safety in pregnancy.

more...
| Case series/case reports  

Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the…

more...
| Case series/case reports  

The mainstay of control of the COVID-19 pandemic is vaccination against SARS-CoV-2.

more...
| Case series/case reports  

In this article the authors report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving…

more...
| Observational study: prospective longitudinal cohort  

Whether or not persons who have already been infected SARS-CoV-2 should be vaccinated is unclear.

more...
| Observational study: prospective longitudinal cohort  

Interim results from a phase 3 trial of the Moderna mRNA-1273 SARS-CoV-2 vaccine indicated 94% efficacy in preventing COVID-19.

more...
| Observational study: prospective longitudinal cohort  

Since the start of the vaccination campaign, the development of COVID-19 has been reported in persons who have received one or both doses of mRNA-1273…

more...
| Observational study: prospective longitudinal cohort  
more...